Revvity ($RVTY) Stock Forecast: Down 5.2% Today

What is Revvity?

Revvity Inc. ($RVTY) is a healthcare company drawing attention recently for its financial performance and investor activities. The stock witnessed a significant bearish movement today amidst institutional transactions and market uncertainties.

Why is Revvity going down?

RVTY stock is down 5.2% on Mar 12, 2026 16:42

• A notable institution, Barclays PLC, decreased its stake in Revvity by 11.5%, potentially reflecting concerns about the company's future prospects and influencing the bearish market movement.
• Conversely, Neuberger Berman Group LLC notably augmented its holdings in Revvity, indicating varying sentiments among institutional investors about the stock's potential.
• Investor enthusiasm for Revvity may have been tempered by a Bretton Fund letter cautioning about the 2026 outlook and scrutinizing capital allocation, potentially contributing to the downward trend.
• The unexpected decline in nonfarm payroll jobs, affecting the healthcare sector and Revvity among others, intensified market uncertainty and contributed to the stock's overall decline.

RVTY Price Chart

RVTY Technical Analysis

RVTY News

Barclays PLC Sells 37,149 Shares of Revvity Inc. $RVTY

Barclays PLC reduced its stake in Revvity Inc. by 11.5% in the third quarter, selling 37,149 shares and retaining 285,769 shares valued at $25.048 million. Despite this, several other institutional investors either initiated new positions or increased their holdings in Revvity. The article also provides a summary of Revvity's recent financial performance, including its latest quarterly earnings which surpassed analyst estimates, and recent analyst ratings, noting an average "Hold" rating with a consensus target price of $113.67.

https://www.marketbeat.com/instant-alerts/filing-barclays-plc-sells-37149-shares-of-revvity-inc-rvty-2026-03-12/

Understanding Momentum Shifts in (RVTY)

This article analyzes momentum shifts in Revvity Inc. (NASDAQ: RVTY), highlighting a weak near-term sentiment but an exceptional 36.6:1 risk-reward setup. It presents three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, alongside a multi-timeframe signal analysis. The analysis suggests a potential 10.8% gain versus 0.3% risk, with current signals indicating neutral sentiment.

https://news.stocktradersdaily.com/news_release/101/Understanding_Momentum_Shifts_in_RVTY_031026063001_1773138601.html

Neuberger Berman Group LLC Buys 450,648 Shares of Revvity Inc. $RVTY

Neuberger Berman Group LLC significantly increased its stake in Revvity Inc. (RVTY) by 4,598.9% in the third quarter, purchasing an additional 450,648 shares. Other institutions like EdgePoint and Invesco also raised their holdings, bringing institutional ownership in Revvity to 86.65%. Revvity surpassed Q3 earnings estimates and provided optimistic FY2026 guidance, while maintaining a quarterly dividend.

https://www.marketbeat.com/instant-alerts/filing-neuberger-berman-group-llc-buys-450648-shares-of-revvity-inc-rvty-2026-03-07/

The Bull Case For Revvity (RVTY) Could Change Following Cautious 2026 Outlook And Capital Allocation Scrutiny

Revvity recently reported Q4 2025 results and issued a cautious 2026 outlook, aligning with reduced analyst expectations. A Bretton Fund letter criticized the company's capital allocation, specifically the use of Covid testing windfalls for overpriced acquisitions and divestitures, raising concerns about future investments and their alignment with growth and margin expansion. This scrutiny over capital allocation decisions, combined with a conservative 2026 forecast, may temper the previously optimistic investment narrative for Revvity.

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-rvty/revvity/news/the-bull-case-for-revvity-rvty-could-change-following-cautio

Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know

A number of healthcare stocks, including Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco, experienced significant drops in share price following an unexpected contraction in nonfarm payroll jobs reported by the Bureau of Labor Statistics for February, particularly impacting the healthcare sector. Investors are concerned about a potential economic slowdown and its effect on healthcare spending. The article also touches on a previous stock drop for Revvity due to new global tariffs announced by the Trump administration.

https://stockstory.org/us/stocks/nyse/thc/news/why-up-down/tenet-healthcare-revvity-avantor-azenta-and-elanco-shares-plummet-what-you-need-to-know

Trending Today

PancakeSwap ($CAKE) Crypto Forecast: Up 5.3% Today

Revvity Price History

22.00.2026 - RVTY Stock was up 5.3%

• Today's positive movement in Revvity can be linked to the optimistic investor sentiment driven by the company's robust financial performance and strategic partnerships.
• The partnership announcement with Eli Lilly to incorporate AI models into Revvity Signals platform likely bolstered investor trust in the company's future growth possibilities.
• The acquisition of a significant stake by Campbell & CO Investment Adviser LLC and Revvity's sanctioned share buyback program reflect confidence from institutional investors and the company itself.
• The recently finalized $650 million sale of Avantor's clinical services business to Revvity may have also played a part in the positive trend, highlighting Revvity's tactical expansion and potential for increased revenue.

12.01.2026 - RVTY Stock was down 7.6%

• Despite introducing new automation platforms, such as the Opera Phenix OptIQ system and EnVision Nexus One plate reader, at a recent industry event, Revvity's stock faced a bearish trend.
• The company's valuation being 27.4% below estimated fair value and a share price 15% below analyst targets might have contributed to the negative market movement.
• Investors are advised to closely monitor the adoption of these new platforms, their impact on revenue growth, and any adjustments to analyst forecasts to gauge the stock's future performance accurately.

12.01.2026 - RVTY Stock was down 5.2%

• Revvity's launch of innovative high-throughput discovery and automation platforms at SLAS2026 is intended to meet the need for quicker experiments and streamlined processes in labs, potentially driving recurring revenue.
• However, despite these advancements, the stock's downward trend may be attributed to concerns surrounding the company's diminishing 1, 3, and 5-year returns, alongside its valuation falling below projected fair value and analyst estimations.
• Investors' response to existing risks associated with Revvity, like its relatively high P/E ratio and highlighted concerns about one-time items impacting reported earnings, likely contributed to today's bearish market performance.

06.02.2026 - RVTY Stock was down 5.1%

• Revvity's stock exhibited a downward trend today, influenced by general market uncertainties and concerns regarding its capital allocation strategies.
• The unexpected decline in healthcare employment noted in the February jobs report has raised apprehensions about diminishing healthcare expenditure and demand, affecting companies in the healthcare sector like Revvity.
• Interrogations regarding Revvity's conservative 2026 outlook and capital allocation methods have prompted investors to reassess the company's prospects for growth, resulting in a downturn in the stock price.
• Despite the immediate hurdles, Revvity's strong array of products and ability to generate cash indicate that holding onto the stock in investment portfolios could be logical for long-term investors interested in its growth potential.

06.02.2026 - RVTY Stock was down 6.5%

• Revvity's stock has experienced bearish trends due to caution in the 2026 forecasts and investor apprehensions about capital allocation.
• Despite positive earnings and a promising FY2026 outlook, investor focus on capital management and its implications on future growth has overshadowed the company's strong fundamentals.
• Changes in Citigroup Inc.'s stake and increased institutional ownership indicate a mix of investor sentiments toward Revvity, contributing to the downward movement in stock value.
• The downward trajectory in Revvity's stock price today is attributed to market uncertainties regarding the company's capital allocation strategy and its potential impact on growth, shaping the prevailing bearish sentiment.

03.01.2026 - RVTY Stock was up 1.5%

• Analysts from several firms, such as TD Cowen, Evercore ISI Group, Wells Fargo, and KeyBanc, have increased their price targets for Revvity stock, indicating a favorable outlook for the company.
• The company's impressive Q4 performance, surpassing adjusted earnings expectations and providing a positive fiscal 2026 outlook, has led to the heightened price targets and ratings.
• Revvity's board approving a $1.0 billion share buyback program has also influenced analysts' recommendations and contributed to the upward movement in the stock.
• The optimistic future outlook, strong financial results, and positive analyst assessments have collectively driven the bullish trend for Revvity (RVTY) stock.

03.01.2026 - RVTY Stock was down 5.3%

• An analyst raised Revvity's price target to $124 from $120, reflecting a 15% premium over the current share price, but the stock saw a pre-market decline, possibly leading to profit-taking by investors.
• Despite positive momentum indicators and analyst upgrades, including from another firm, the market movement could be influenced by broader market trends or sector-specific challenges impacting investor sentiment.
• The strong Q4 results and optimistic fiscal 2026 outlook may have already been priced into the stock, leading to a sell-off after the earnings announcement as investors locked in gains.
• Overall, the bearish movement in Revvity's stock today could be a result of a combination of profit-taking, market dynamics, and potential overvaluation following the recent price target upgrades and positive analyst forecasts.

13.00.2026 - RVTY Stock was up 5.3%

• Revvity's stock saw a strong bullish movement today, rising by 6.9% ahead of the U.S. stock market open.
• The positive market response could be attributed to the company's recent guidance hike and exceeding the top-end of its EPS and revenue guidance, indicating stronger-than-expected financial performance.
• Investors might be optimistic about Revvity's upcoming earnings report and the anticipated financial results, with revenue expectations for the fourth quarter and full year 2025 looking promising.
• The presentation suggesting that existing end market trends will continue into 2026 could have also contributed to the bullish sentiment surrounding Revvity's stock today.

13.00.2026 - RVTY Stock was up 7.7%

• Revvity stock surged by 6.9% in premarket trading, following a 5% jump after the company raised its full-year profit outlook. This positive guidance hike ahead of the earnings report seems to have instilled confidence in investors.
• The company exceeded the top-end of its EPS and revenue guidance, indicating robust financial performance. This unexpected positive news likely contributed to the bullish movement in the stock price.
• With Revvity expecting to surpass its Q4 guidance with 6% revenue growth and adjusted earnings per share above previous estimates, investors are optimistic about the company's future financial health.
• The upcoming earnings call on February 2, 2026, where Revvity will provide a detailed update on its financial performance, is anticipated to be a key event that investors are looking forward to, driving the bullish sentiment further.

04.02.2026 - RVTY Stock was up 5.3%

• The positive performance of Revvity Inc. ($RVTY) today is correlated with its robust quarterly earnings results and optimistic future guidance.
• Despite recent challenges in share price and competition, the encouraging earnings report and positive outlook have instilled confidence among investors, leading to an upward trend in the stock.
• The increased interest from notable institutional investors, like Mitsubishi UFJ Asset Management Co. Ltd., reflects confidence in Revvity's future, contributing to its stock price increase.
• Different methods of valuation present varying perspectives, with DCF models indicating undervaluation and P/E ratios suggesting overvaluation. This disparity may have caused some fluctuations, but investors continue to capitalize on the positive earnings momentum.

12.02.2026 - RVTY Stock was down 5.2%

• A notable institution, Barclays PLC, decreased its stake in Revvity by 11.5%, potentially reflecting concerns about the company's future prospects and influencing the bearish market movement.
• Conversely, Neuberger Berman Group LLC notably augmented its holdings in Revvity, indicating varying sentiments among institutional investors about the stock's potential.
• Investor enthusiasm for Revvity may have been tempered by a Bretton Fund letter cautioning about the 2026 outlook and scrutinizing capital allocation, potentially contributing to the downward trend.
• The unexpected decline in nonfarm payroll jobs, affecting the healthcare sector and Revvity among others, intensified market uncertainty and contributed to the stock's overall decline.

14.00.2026 - RVTY Stock was up 5.1%

• Following the release of upbeat Q4 earnings forecasts, Revvity's stock experienced a notable surge, underlining robust revenue expansion.
• Market analysts have backed the stock with a "Buy" recommendation, setting an average price target of $120.24, which has heightened investor confidence in the company's trajectory.
• While concerns surrounding the stock's potential overvaluation based on the P/E ratio have surfaced, the positive anticipated financial performance and optimistic 2026 outlook have eclipsed these reservations, propelling the bullish market sentiment.
• The upcoming earnings call and the CEO's presentation at the J.P. Morgan Healthcare Conference are poised to offer additional insights into Revvity's financial standing and future growth prospects, potentially sustaining the positive momentum surrounding the stock.